Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga·07/15/2025 12:40:03

Listen to the news

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Tuesday.

Shares of Simulations Plus, Inc (NASDAQ:SLP) fell sharply in pre-market trading after the company reported downbeat third-quarter sales and cut its FY2025 EPS guidance.

Simulations Plus reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 7 cents pers hare. The company reported quarterly sales of $20.363 million which missed the analyst consensus estimate of $20.878 million.

Keybanc analyst Scott Schoenhaus downgraded Simulations Plus from Overweight to Sector Weight.

Simulations Plus shares dipped 6.3% to $16.37 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

Presidio Property Trust, Inc. (NASDAQ:SQFT) shares dipped 29.9% to $9.55 in pre-market trading after jumping 166% on Monday. The company announced the pricing of a $2.05 million registered direct offering of 170,830 shares at $12.00 per share.
MiNK Therapeutics, Inc. (NASDAQ:INKT) declined 27.5% to $29.45 in pre-market trading after dipping 37% on Monday. William Blair analyst Matt Phipps, on Monday, downgraded MiNK Therapeutics from Outperform to Market Perform.
Organogenesis Holdings Inc. (NASDAQ:ORGO) dropped 26.7% to $3.29 in pre-market trading after gaining over 4% on Monday.
MiMedx Group, Inc. (NASDAQ:MDXG) fell 20.7% to $5.38 in pre-market trading.
Sequans Communications S.A. (NYSE:SQNS) declined 10.8% to $5.01 in pre-market trading. Sequans shares gained around 20% on Monday after the company announced it bought 683 more Bitcoins and provided updates on its total holdings.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) declined 5.5% to $1.8990 in pre-market trading.
FB Financial Corporation (NYSE:FBK) fell 5.4% to $46.50 in pre-market trading following downbeat quarterly sales.
ProKidney Corp. (NASDAQ:PROK) fell 4.6% to $3.52 in pre-market trading. ProKidney filed for common stock offering of up to $200 million.
Blue Gold Limited (NASDAQ:BGL) declined 4.5% to $26.60 in pre-market trading after surging 30% on Monday.

Now Read This:

JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Tuesday

Photo via Shutterstock

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English